AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Attenuated Vaccine for Canine Ehrlichiosis (Yissum)

Summary
Vaccine for the prevention of ehrlichiosis in dogs and other canine species

Bacterial tick-borne disease affects dogs and other canines throughout the United States and worldwide

Initial effect seen in small sample

Challenged Dogs did not developed clinical signsAttenuated strain of E. canis prepared through serial passage in tissue culture is used to prepare a vaccine that effectively prevents ehrlichiosis in caninesInduces protective immunity against clinical manifestation of the disease

Proprietary strain of Ehrlichia canis

Low bacterial load post challenge in the vaccinated dogsLooking for commercial partners for further development and commercialisation purposes
Technology Benefits
Ehrlichiosis is one of the most common infectious diseases in canines

Found in pet dogs as well as foxes, wolves, jackals and other wild canines
ID No.
8-2007-1839
Country/Region
Israel

For more information, please click Here
Mobile Device